World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
43
Citations
7683
World Ranking
4841
National Ranking
404

Jill Gilmour publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jill Gilmour sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 160 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jill Gilmour D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jill Gilmour sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 43 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jill Gilmour is affiliated with Imperial College London in the United Kingdom. Their research primarily spans the fields of Immunology and Microbiology with a significant focus on Medicine. The subfields contributing to their scientific output include Virology, Immunology, Infectious Diseases, Molecular Biology, and Emergency Medicine.

Their work addresses multiple topics centered on HIV research and treatment, including HIV/AIDS research and interventions, vaccines and immunoinformatics approaches, immune cell function and interaction, HIV/AIDS drug development and treatment, and HIV-related health complications and treatments.

Frequent co-authors in Jill Gilmour's research include:

  • Eric Hunter
  • William Kilembe
  • Jonathan Hare
  • Eduard J. Sanders
  • Etienne Karita

Their publications are often featured in several key venues, with multiple papers appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • Frontiers in Immunology
  • PLoS ONE
  • PLoS Pathogens

Notable recent papers include:

  • "African-led health research and capacity building- is it working?", 2020, BMC Public Health
  • "HIV-1 variants are archived throughout infection and persist in the reservoir", 2020, PLoS Pathogens
  • "Identifying the immune interactions underlying HLA class I disease associations", 2020, eLife
  • "Cohort Profile: IAVI's HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery", 2020, International Journal of Epidemiology
  • "A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome", 2021, Clinical Infectious Diseases

Best Publications

  • Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load

    Heather Donaghy;Anton Pozniak;Brian Gazzard;Nad Qazi

  • Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort

    Elise Landais;Xiayu Huang;Colin Havenar-Daughton;Ben Murrell

  • Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes

    Nilu Goonetilleke;Stephen Moore;Len Dally;Nicola Winstone

  • International Seroepidemiology of Adenovirus Serotypes 5, 26, 35, and 48 in Pediatric and Adult Populations

    Dan H. Barouch;Dan H. Barouch;Sandra V. Kik;Gerrit J. Weverling;Rebecca Dilan

  • Selection bias at the heterosexual HIV-1 transmission bottleneck

    Jonathan M. Carlson;Malinda Schaefer;Daniela C. Monaco;Rebecca Batorsky

  • Standardization of cytokine flow cytometry assays

    Holden T Maecker;Aline Rinfret;Patricia D'Souza;Janice Darden

  • Plasmacytoid Dendritic Cells Are Highly Susceptible to Human Immunodeficiency Virus Type 1 Infection and Release Infectious Virus

    Steven Patterson;Aaron Rae;Nicola Hockey;Jill Gilmour

  • In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers.

    Sandhya Vasan;Arlene Hurley;Arlene Hurley;Sarah J. Schlesinger;Sarah J. Schlesinger;Drew Hannaman

  • Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1

    Nicola Borthwick;Tina Ahmed;Beatrice Ondondo;Peter Hayes

  • CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa

    Etienne Karita;Nzeera Ketter;Matt A. Price;Kayitesi Kayitenkore

  • Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients

    Hayley Crawford;Wendy Lumm;Alasdair Leslie;Malinda Schaefer

  • Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children.

    Louise Kim;Mark Johnson;Simon Barton;Mark Nelson

  • Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity

    Barry S. Peters;Walter Jaoko;Eftyhia Vardas;George Panayotakopoulos

  • Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.

    Matt A. Price;Carole L. Wallis;Shabir Lakhi;Etienne Karita

  • Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.

    Frances H Priddy;David J M Lewis;Huub C Gelderblom;Hana Hassanin

  • Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

    Pauli N. Amornkul;Etienne Karita;Anatoli Kamali;Wasima N. Rida

  • Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa.

    Walter Jaoko;Etienne Karita;Kayitesi Kayitenkore;Gloria Omosa-Manyonyi

  • Impact of pre-Adapted HIV transmission

    Jonathan M Carlson;Victor Y Du;Nico Pfeifer;Anju Bansal

  • Role of Transmitted Gag CTL Polymorphisms in Defining Replicative Capacity and Early HIV-1 Pathogenesis

    Jessica L. Prince;Daniel T. Claiborne;Jonathan M. Carlson;Malinda Schaefer

  • Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.

    Walter Jaoko;Frederick N. Nakwagala;Omu Anzala;Gloria Omosa Manyonyi

Frequent Co-Authors

Eric Hunter
Eric Hunter Emory University
Matthew Price
Matthew Price University of Vermont
Eduard J. Sanders
Eduard J. Sanders University of Oxford
Susan Allen
Susan Allen Emory University
Anatoli Kamali
Anatoli Kamali International AIDS Vaccine Initiative
Patricia E. Fast
Patricia E. Fast International AIDS Vaccine Initiative
Josephine H. Cox
Josephine H. Cox National Institute of Allergy and Infectious Diseases
Pontiano Kaleebu
Pontiano Kaleebu London School of Hygiene & Tropical Medicine
Paul A. Goepfert
Paul A. Goepfert University of Alabama at Birmingham
Philip J. R. Goulder
Philip J. R. Goulder University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their studies related to Immunology, online nursing programs offer a practical pathway. Many students explore the easiest np program options to balance rigorous coursework with hands-on experience. This approach helps build foundational skills that complement immunological knowledge.

Specializing further, the best online pmhnp programs provide strong clinical placement opportunities, crucial for those focusing on psychiatric and mental health nursing careers. These pathways can intersect with immunology, especially in understanding neuroimmune interactions.

Affordability remains a key concern. Prospective students often consider the cheapest psych np programs to pursue advanced degrees without incurring excessive debt. This financial accessibility allows more individuals to contribute effectively to healthcare fields connected to immunology.

Ultimately, career growth in these areas is promising. According to research on the highest paid dnp specialties, nurse practitioners specializing in psychiatric and mental health fields often achieve lucrative salaries, reflecting the demand and expertise required.

Best Scientists Citing Jill Gilmour

Trending Scientists

Recently Published Articles